Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

97 trials with published results (11%)

Research Maturity

571 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.8%

52 terminated out of 889 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

19%

167 trials in Phase 3/4

Results Transparency

17%

97 of 571 completed with results

Key Signals

97 with results92% success52 terminated

Data Visualizations

Phase Distribution

515Total
Not Applicable (215)
Early P 1 (9)
P 1 (51)
P 2 (73)
P 3 (58)
P 4 (109)

Trial Status

Completed571
Unknown144
Recruiting59
Terminated52
Active Not Recruiting25
Withdrawn21

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 571 completed trials

Clinical Trials (889)

Showing 20 of 20 trials
NCT06788431Early Phase 1RecruitingPrimary

A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.

NCT01143480Recruiting

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

NCT05622929Not ApplicableCompleted

Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control

NCT01399385Not ApplicableRecruiting

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT07524101Not ApplicableNot Yet Recruiting

Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

NCT06013722Not ApplicableActive Not RecruitingPrimary

Strategy for Unstable Coronary Plaque in Patients Presenting to Emergency Department for Chest Pain Suspected of Coronary Artery Disease

NCT07521007Phase 2Not Yet RecruitingPrimary

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

NCT01143454Recruiting

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT07448038Phase 2RecruitingPrimary

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

NCT03037411Completed

A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries

NCT00353782Recruiting

Causes and Natural History of Dyslipidemias

NCT03228459Not ApplicableActive Not RecruitingPrimary

The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease

NCT06579807Not ApplicableRecruiting

Cardiac Rehabilitation and Coronary Artery Disease

NCT06676046Recruiting

Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions

NCT04505865Not ApplicableRecruitingPrimary

The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease

NCT05124249Recruiting

Imaging and Physiologic Evaluation of Coronary Artery Disease

NCT00756379Not ApplicableActive Not Recruiting

Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease

NCT02932176RecruitingPrimary

Machine Learning for Handheld Vascular Studies

NCT06488105Phase 2Recruiting

Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

NCT04607070Completed

Ischemic Strokes While on NOAC - How Compliance Matters

Scroll to load more

Research Network

Activity Timeline